How Has The Genotyping Market Size Evolved Historically?
The genotyping market has seen considerable growth due to a variety of factors.
•The expansion of the genotyping market has been swift in the past few years. The market is predicted to escalate from $23.04 billion in 2024 to $26.63 billion in 2025, with a compound annual growth rate (CAGR) of 15.6%.
The growth during the historical period is ascribed to governmental efforts and financial support, swift reduction in the costs associated with genotyping, expansion in the number and size of biobanks and genetic databases, rising case numbers of genetic disorders, and advancements in pharmacogenomics and drug development.
What Will Be The Genotyping Market Size In The Future?
The genotyping market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the genotyping market is predicted to experience swift expansion. It is projected to reach $51.43 billion by 2029, with a compound annual growth rate (CAGR) of 17.9%.
This upswing during the forecast phase can be tied to its increased usage in clinical diagnostics, the growing appeal of personalized medicine, surge in research and development ventures, and broader applications in agriculture and livestock sectors. Main trends expected during the prediction period includes increased demand for pharmacogenomics, innovations in next-generation sequencing (ngs), growth of precision medicine initiatives, expansion of direct-to-consumer (dtc) genetic testing, and a heightened focus on cancer genomics and personalized treatments.
What Are The Key Drivers Fueling Growth In The Genotyping Market?
The growth of the genotyping market is expected to be driven by the increasing instances of cancer and genetic disorders. Cancer represents a wide range of diseases that can occur in virtually any organ or tissue in the body, and genetic disorders are conditions that are wholly or partially caused by a variation from the normal DNA sequence. Genotyping enables researchers to explore genetic anomalies such as single nucleotide variations, copy number variations, and significant DNA structural changes. Genotyping or genetic testing is used to identify particular gene mutations that could increase a person's susceptibility to certain types of cancer. For example, the World Health Organization, a Switzerland-based agency with a focus on global public health, reported in February 2024 that in 2022, around 20 million new cancer cases were reported, leading to 9.7 million deaths. In addition, roughly 53.5 million people were still alive five years after a cancer diagnosis. Additionally, in February 2023, Gene People UK, a registered charity based in the UK, estimated that 1 in 25 children suffers from a hereditary condition. This suggests that 30,000 children and babies are diagnosed annually in the UK, and over 2.4 million children and adults suffer from a genetic disorder. Thus, the rising occurrence of cancer and genetic disorders is fueling the expansion of the genotyping market.
What Are The Principal Market Segments In The Global Genotyping Industry?
The genotyping market covered in this report is segmented –
1) By Product And Services: Instruments, Reagents And Kits, Bioinformatics, Genotyping Service
2) By Technology: Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction, Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry, Other Technologies
3) By Application: Pharmacogenomics, Diagnostics And Personalized Medicine, Animal Genetics, Agricultural Biotechnology, Other Applications
4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Diagnostics And Research Laboratories, Academic Institutes, Other End-Users
Subsegments:
1) By Instruments: Sequencers, PCR Machines, Microarrays, Genotyping Platforms
2) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Next-Generation Sequencing (NGS) Kits
3) By Bioinformatics: Data Analysis Software, Genomic Data Management Tools, Cloud-based Solutions
4) By Genotyping Services: Contract Research Organizations (CRO) Services, Custom Genotyping Services, Sample Preparation Services
Pre-Book The Genotyping Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Genotyping Sector?
The emergence of product innovations is a significant trend gaining momentum in the genotyping market. Businesses in the genotyping industry are leveraging inventive solutions to maintain their market stand. For example, in May 2022, US-based entities Neogen, a food safety enterprise, and Gencove Inc., a provider for a genomic discovery sequencing platform, introduced InfiniSEEK. This initiative is a novel and budget-friendly solution for whole genome sequencing and targeted SNP (single nucleotide polymorphism) analysis, making it the initial whole-genome and genotyping sequencing remedy for cattle breeders. InfiniSEEK has provided the sector with a reliable tool to manage over 400 bovine genetic traits and conditions, unearth new factors affecting favorable phenotypes, and reduce selection bias through sequencing more or every member of a population. The launch of this distinctive service has equipped consumers with an information-rich, budget-friendly technique for profiling cattle globally by integrating genome-wide sequencing data, specific genetic attributes, and parentage indicators.
Who Are the Key Players in the Genotyping Market?
Major companies operating in the genotyping market include:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• Eurofins Scientific SE
• Agilent Technologies
• PerkinElmer Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN NV
• BGI Genomics
• LGC Biosearch Technologies
• GenScript Biotech
• Inotiv
• Takara Bio Inc.
• Integrated DNA Technologies Ltd.
• 23andMe Inc.
• Novogene Corporation
• Oxford Nanopore Technologies
• Macrogen Inc.
• Pacific Biosciences of California
• Standard BioTools Inc.
• GENEWIZ
• Transnetyx
• Agena Bioscience Inc.
• Genotypic Technology Pvt Ltd.
• BMG LABTECH GmbH
• Bioline
• Biofortuna Limited
• Xcelris Genomics
What are the Regional Insights into the Genotyping Market?
North America was the largest region in genotyping market in 2024. The regions covered in the genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
